Highly Favorable Outcomes With Rt Followed by Asct in Low/Low-Intermediate Secondary Age Adjusted Ipi Rel/Ref DLBCL Patients Refractory to Salvage Chemotherapy

Hematological Oncology - United Kingdom
doi 10.1002/hon.69_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Poor Outcomes of Patients With Relapsed/Refractory DLBCL Requiring More Than One Salvage Therapy Followed by Autologous HCT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Very Early FDG Pet/Ct Scan May Predict Outcomes in Relapsed or Refractory DLBCL Patients Treated With Salvage Therapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

R-Ivac Salvage Therapy in Relapsed and Refractory DLBCL

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Highly Favorable Preliminary Clinical and Toxicity Outcomes for Low- And Intermediate-Risk Prostate Cancer Patients Treated With High-Dose-Rate Brachytherapy in a Single Fraction of 19 Gy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Outcomes of Autologous Stem Cell Transplantation (ASCT) in Patients With Relapsed/Refractory HIV-associated Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2016English

Toxicity-Reduced, Myeloablative Allograft Followed by Lenalidomide Maintenance as Salvage Therapy for Refractory/Relapsed Myeloma Patients

Bone Marrow Transplantation
TransplantationHematology
2012English

Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2007English

Significance of Salvage Autologous Stem Cell Transplantation (ASCT) for Patients With Multiple Myeloma Relapsing After Up-Front ASCT

Journal of Hematopoietic Cell Transplantation
2017English

High Dose Chemotherapy (HDT) With Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (Pts) With High Risk Solid Tumors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy